MRK Stock
Merck & Co., Inc.
—
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
Valuation
P/E (trailing)134.4
Forward P/E18.7
Price / sales4.9
Price / book8.0
EPS (12 mo)$0.98
Dividend yield2.87%
Beta0.20
Financial health last 12 months
Revenue growth+4.9%
Earnings growth-87.0%
Gross margin76.6%
Net margin+3.6%
Return on equity5.3%
Debt / equity1.20
Hover a figure for what it means.
Analyst ratings Nov 2026 · 35 analysts
Consensus: Buy
Strong buy 8Buy 17
Hold 10Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 25 | 10 | 0 | Buy |
| Oct 2026 | 26 | 9 | 0 | Buy |
| Sep 2026 | 26 | 10 | 0 | Buy |
| Aug 2026 | 25 | 11 | 0 | Buy |
Latest news
Clorox vs. Merck: 49 and 15 Straight Years of Raises. Which Dividend Pays You More in 10 Years?
Yahoo · 12h ago
Merck Sinks 9.5% in a Week as It Scraps a Blood Cancer Drug and Healthcare Sells Off. Time to Buy?
Yahoo · 21h ago
Learn Why The Bull Case For Moderna (MRNA) Could Change Following Melanoma Vaccine Trial Results
Yahoo · 1d ago
What A Cancer Vaccine Stumble Means For Moderna Stock
Yahoo · 1d ago
Dividend Champion, Contender, And Challenger Highlights: Week Of November 22
SeekingAlpha · 1d ago
What Does Eli Lilly Offer That Merck Does Not?
Yahoo · 1d ago
MSD and Isomorphic join forces to develop oncology drugs
Yahoo · 1d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.